Received Feb 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received a first dose back on twenty twenty-two.he first dose vaccination date for this SHINGRIX vaccine was back on December 2022; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on DEC-2022). The patient did not receive the 2nd dose of Shingrix. After receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received a first dose back on twenty twenty-two.he first dose vaccination date for this SHINGRIX vaccine was back on December 2022). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date:11-FEB-2026 The batch number was not provided, and we are unable to contact the reporter.